These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 6343958

  • 21. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
    Casals-Stenzel J, Tree M, Brown JJ, Fraser R, Lever AF, Millar JA, Morton JJ, Robertson JI, Reid JL, Hamilton C.
    J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
    [Abstract] [Full Text] [Related]

  • 22. The effect of spironolactone in hypertensive patients on regular haemodialysis and after renal allotransplantation.
    Papadimitriou M, Vyzantiadis A, Milionis A, Memmos D, Metaxas P.
    Life Support Syst; 1983 Jun; 1(3):197-205. PubMed ID: 6433115
    [Abstract] [Full Text] [Related]

  • 23. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M, Guyene TT, Chatellier G, Ménard J.
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [Abstract] [Full Text] [Related]

  • 24. [Effect of coffee on blood pressure and activity renin-angiotensin- aldosterone system and catecholamines concentration in patients with essential hypertension].
    Mazurek W, Negrusz-Kawecka M.
    Pol Merkur Lekarski; 1999 Oct; 7(40):159-63. PubMed ID: 10835904
    [Abstract] [Full Text] [Related]

  • 25. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR, Lopes KL, Carillo BA, Bergamaschi CT, Carmona AK, Casarini DE, Furukawa L, Heimann JC, Campos RR, Dolnikoff MS.
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [Abstract] [Full Text] [Related]

  • 26. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.
    Azizi M, Ménard J, Bissery A, Guyenne TT, Bura-Rivière A, Vaidyanathan S, Camisasca RP.
    J Am Soc Nephrol; 2004 Dec; 15(12):3126-33. PubMed ID: 15579516
    [Abstract] [Full Text] [Related]

  • 27. Electrolytes and sodium transport mechanism in diabetes mellitus.
    Shahid SM, Rafique R, Mahboob T.
    Pak J Pharm Sci; 2005 Apr; 18(2):6-10. PubMed ID: 16431390
    [Abstract] [Full Text] [Related]

  • 28. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.
    Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T.
    Arch Intern Med; 1981 Nov; 141(12):1589-93. PubMed ID: 7030245
    [Abstract] [Full Text] [Related]

  • 29. Plasma renin activity in hypertensive diseases.
    Itasaka Y.
    Nagoya J Med Sci; 1970 Jul; 33(1):31-45. PubMed ID: 5453994
    [No Abstract] [Full Text] [Related]

  • 30. pH-independent inhibition of plasma angiotensin I degradation: implications for renin assay.
    Ryan MP, Li TK, Weinberger MH.
    Clin Chim Acta; 1979 Oct 15; 98(1-2):67-76. PubMed ID: 115624
    [Abstract] [Full Text] [Related]

  • 31. [Patient-adapted, ion selective analysis--characteristics of a new instrument].
    Dennhardt R, Frucht U, Leuchtmann D.
    Anasth Intensivther Notfallmed; 1987 Dec 15; 22(6):294-7. PubMed ID: 3439593
    [Abstract] [Full Text] [Related]

  • 32. [Effects of electroconvulsive shock on rénin activity and plasma electrolytes].
    Jimeno Carruéz A, Najaty Jabarí S, Díaz González G, Largo Cabrerizo E, Usategui Echeverría R, Fernandez Renedo C, Ortíz Manchado O.
    Rev Clin Esp; 1975 Nov 30; 139(4):309-12. PubMed ID: 1208910
    [No Abstract] [Full Text] [Related]

  • 33. Immunochemical differences between angiotensin I-forming enzymes in man.
    Menard J, Galen FX, Devaux C, Kopp N, Auzan C, Corvol P.
    Clin Sci (Lond); 1980 Dec 30; 59 Suppl 6():41s-44s. PubMed ID: 7004732
    [Abstract] [Full Text] [Related]

  • 34. The site of angiotensin production.
    Campbell DJ.
    J Hypertens; 1985 Jun 30; 3(3):199-207. PubMed ID: 3894514
    [No Abstract] [Full Text] [Related]

  • 35. [Inhibition of acid-activation of inactive renin by heparin].
    Aoi W, Akahoshi M, Takahara A, Seto S, Hashiba K.
    Nihon Jinzo Gakkai Shi; 1987 Aug 30; 29(8):1071-6. PubMed ID: 3320422
    [No Abstract] [Full Text] [Related]

  • 36. [Extreme results in electrolyte determination].
    Vogt W, Oesterle B.
    Wien Klin Wochenschr Suppl; 1992 Aug 30; 192():21-7. PubMed ID: 1502820
    [Abstract] [Full Text] [Related]

  • 37. The metabolic load of stored blood. Implications for major transfusions in infants.
    Ratcliffe JM, Elliott MJ, Wyse RK, Hunter S, Alberti KG.
    Arch Dis Child; 1986 Dec 30; 61(12):1208-14. PubMed ID: 3813612
    [Abstract] [Full Text] [Related]

  • 38. Angiotensin I-generating acid endopeptidase activity in neurosecretory vesicles isolated from bovine pituitary.
    Gainer H, Russell JT, Loh YP.
    Neuropeptides; 1984 Nov 30; 4(6):447-55. PubMed ID: 6392922
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.